Ledger.Open graph →
SEC Form D · Amendment · filed September 26, 2024

C2N Diagnostics, LLC

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ST. LOUIS, MO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Dr. Joel Braunstein · St. Louis, MOExec · DirectorDr. Michael Goldblatt · St. Louis, MODirectorMicah Onixt · St. Louis, MOExecDr. David Holtzman · St. Louis, MODirectorDr. Randall Bateman · St. Louis, MODirectorDr. David Holtzman · St. Louis, MODirectorDr. Randall Bateman · St. Louis, MODirectorMicah Onixt · St. Louis, MOExecDr. Joel Braunstein · St. Louis, MOExec · DirectorDr. Michael Goldblatt · St. Louis, MODirectorWayne Brownlee · Saskatoon, Saskatchewan, CanadaDirectorJohn Knowles · Saskatoon, Saskatchewan, CanadaDirectorLionel Marks De Chabris · Saskatoon, Saskatchewan, CanadaExecKeith Carpenter · Saskatoon, Saskatchewan, CanadaExec · DirectorScott Livingstone · Saskatoon, Saskatchewan, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗